Lukas Greifenstein
3PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Jan 28, 2026
Alpha Therapy Beyond TOC and TATE-Production, Quality Control, and In-Human Results for the SSTR2 Antagonist DOTA-LM3.Lukas Greifenstein, Marcel Martin, Sarah Stephan
|Sep 27, 2025
Peptide Receptor Radionuclide Therapy (PRRT) Using Actinium-225- and Ac-225/Lutetium-177-Labeled (TANDEM) Somatostatin Receptor Antagonist DOTA-LM3 in Patients with Neuroendocrine Neoplasm: A Retrospective Study Concerning Safety and Survival.Elisabetta Perrone, Maria Lucia Calcagni, Lucia Leccisotti
|Dec 11, 2022
[68Ga]Ga-DATA5m-LM4, a PET Radiotracer in the Diagnosis of SST2R-Positive Tumors: Preclinical and First Clinical Results.Panagiotis Kanellopoulos, Berthold A Nock, Lukas Greifenstein
Pageof 1
Frequent Collaborators
2 joint publications
Richard Paul Baum
1 joint publications
Panagiotis Kanellopoulos
1 joint publications
Berthold A Nock
1 joint publications
Frank Roesch
1 joint publications
Theodosia Maina
1 joint publications
Elisabetta Perrone
1 joint publications
Lucia Leccisotti
1 joint publications
Aleksandr Eismant
1 joint publications
Tanay Parkar
